Back

MRK Stock

Price Chart

📈
Loading chart for MRK...
Powered by TradingView

Detailed Market Analysis

Key Levels

Support
$114.85
Resistance
$126.93

Volume & Momentum

Volume
Weak
0.8x avg
Momentum
0%
Weak

Trading Setup

HOLD
Entry $120.89
Stop $114.85
Target $126.93
RSI: 50 | Current: $120.89

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

Insider Trading

Insider Role Date Type Value
Guindo Chirfi Chief Marketing … Feb 12 '26 Sale 1214562.0
DEAN LI Officer Feb 10 '26 Proposed Sale 1202844.0
Li Dean Y Executive VP … Feb 10 '26 Sale 1202844.0
JENNIFER ZACHARY Officer Feb 09 '26 Proposed Sale 14485690.0
CHIRFI GUINDO Officer Feb 09 '26 Proposed Sale 2368202.0
Guindo Chirfi Chief Marketing … Feb 09 '26 Sale 1184101.0
Zachary Jennifer EVP, General … Feb 09 '26 Option Exercise 14485690.0
Zachary Jennifer EVP, General … Feb 09 '26 Sale 14485690.0
RICHARD ROBERT DELUCA … Officer Feb 06 '26 Proposed Sale 4557025.0
DAVID WILLIAMS Officer Feb 06 '26 Proposed Sale 609525.0

Source: FinViz — Data may be delayed

MRK News Intelligence (2 articles)

AI-curated news influencing MRK price, sentiment, and trend

Explore All MRK News with AI Analysis
Economy
1 day, 21 hours ago

Strong Results Lifted Merck & Co (MRK) in Q4

TCW funds, an investment management company, released its “TCW Relative Value Large Cap Fund” fourth-quarter 2025 investor letter. A copy …

Impact on MRK: Neutral market sentiment indicated
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)
View full analysis →
Yahoo Finance 94% confidence
Stocks
2 weeks, 3 days ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Pharmaceutical giant Pfizer and French partner Valneva on Monday said they planned to seek regulatory approval for a Lyme disease …

Impact on MRK: The announcement is likely to have a positive impact on Pfizer's (PFE) …
Pfizer and Valneva plan to seek regulatory approval for a Lyme disease vaccine after a … High (80%)
View full analysis →
MarketWatch 80% confidence
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis
Open article